Status Not started Effective start/end date 1/05/25 → 31/10/25
Epidermal Growth Factor Receptor
Pharmacology, Toxicology and Pharmaceutical Science
100%
Lysosome
Medicine and Dentistry
15%
Epidermal Growth Factor Receptor Kinase Inhibitor
Pharmacology, Toxicology and Pharmaceutical Science
11%
Clathrin
Pharmacology, Toxicology and Pharmaceutical Science
11%
Receptor Protein
Pharmacology, Toxicology and Pharmaceutical Science
11%
Protein Tyrosine Kinase Inhibitor
Pharmacology, Toxicology and Pharmaceutical Science
11%
Cancer Growth
Pharmacology, Toxicology and Pharmaceutical Science
11%
Monoclonal Antibody
Pharmacology, Toxicology and Pharmaceutical Science
11%